Early changes in the circulating T cells are associated with clinical outcomes after PD-L1 blockade by durvalumab in advanced NSCLC patients
晚期非小细胞肺癌患者接受度伐利尤单抗阻断PD-L1治疗后,循环T细胞的早期变化与临床结果相关。
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-020-02833-z
Naidus, Elliot; Bouquet, Jerome; Oh, David Y; Looney, Timothy J; Yang, Hai; Fong, Lawrence; Standifer, Nathan E; Zhang, Li
肺癌
肿瘤
T细胞
肿瘤免疫
PD-L1
T细胞
细胞生物学
免疫/内分泌